Scientific Sessions 2025  /  Moving the Needle: Valve Disease in the Young and Moderate Risk  /  Surgical Valve Selection in the Young: Mechanical Valves as mainstay
Logo

American Heart Association

  66
  0

Final ID:

Surgical Valve Selection in the Young: Mechanical Valves as mainstay

  • Ebinger, Joseph  ( Cedars-Sinai Heart Institute , Los Aeles , California , United States )
  • Badhwar, Vinay  ( West Virginia University , Morgantown , West Virginia , United States )
  • Sultan, Ibrahim  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
    • Author Disclosures:
    Joseph Ebinger: DO have relevant financial relationships ; Consultant:Edwards LifeSciences:Past (completed) | Vinay Badhwar: DO NOT have relevant financial relationships | Ibrahim Sultan: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Abbott, Institutional research support and limited consulting:Active (exists now) ; Other (please indicate in the box next to the company name):Terumo Aortic, Institutional research support and limited consulting:Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic, Institutional research support and limited consulting:Active (exists now) ; Other (please indicate in the box next to the company name):Edwards, Institutional research support and limited consulting:Active (exists now) ; Other (please indicate in the box next to the company name):Gore, Institutional research support and limited consulting:Active (exists now) ; Other (please indicate in the box next to the company name):Atricure, Institutional research support and limited consulting:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Moving the Needle: Valve Disease in the Young and Moderate Risk

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Surgical Valve Selection in the Young: Bioprosthetic Valves for the win

Bowdish Michael, Badhwar Vinay

How Low (Risk) Can You Go?: TAVR Should be reserved for high risk patients.

Ouzounian Maral, Thourani Vinod, Prendergast Bernard, Nazif Tamim, Mori Makoto

More abstracts from these authors:
Technological Advances in Participant Identification and Trial Enrollment

Ebinger Joseph

How Should We Measure BP in Clinical Trials?

Ebinger Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available